Euroimmun and Xpedite Diagnostics Partner to Offer Faster, Easier Protocols for DNA Extraction at POC
Posted on 19 Dec 2023
EUROIMMUN (Lübeck, Germany) and Xpedite Diagnostics (Hallbergmoos, Germany) have entered into a strategic partnership for offering faster and easier protocols for DNA extraction at the point-of-care. Current users of the EUROArray diagnostic platform will now have access to the EUROArray SwiftX-traction Kit designed for rapid manual DNA extraction. EUROArray SwiftX-traction significantly reduces the complexity as well as processing time of the DNA extraction. It can extract DNA from different challenging sample types using just a few steps that take less than 30 minutes.
The new extraction method is currently being validated in combination with various CE-marked EUROArray products. Xpedite Diagnostics aims to soon register the extraction kit itself as a CE-IVD device under the European IVD Regulation 2017/746. Xpedite Diagnostics’ partnership with EUROIMMUN demonstrates its technical leadership in offering high-performing and user-friendly nucleic acid extraction solutions. This, combined with its strong expertise in quality management and regulatory affairs, makes Xpedite Diagnostics well-positioned to act as a reliable and efficient contract developer as well as manufacturer for other IVD companies.
“EUROArray SwiftX-traction was tailored specifically to the needs of users of the EUROArray diagnostic platform and is based on our SwiftX Toolbox,” said Dr. Andy Wende, CEO and Head of R&D at Xpedite Diagnostics GmbH. “The development was finished in only a few months and will result in a CE-IVD marked DNA extraction kit. It merges several advantages such as high sensitivity, short workflows, and improved usability. EUROArray SwiftX-traction will enhance customer satisfaction and acceptance, ultimately leading to a better sales position of the EUROArray diagnostic platform in the segments Dermatomycosis, STI testing, and HPV typing.”
Related Links:
EUROIMMUN
Xpedite Diagnostics
